Evidence map›Paper›PMID 32995116›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

HGF Mediates Clinical-Grade Human Umbilical Cord-Derived Mesenchymal Stem Cells Improved Functional Recovery in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.

Yali Jia, Ning Cao, Jinglei Zhai, Quan Zeng, Pei Zheng, Ruyu Su, Tuling Liao, Jiajing Liu, Haiyun Pei, Zeng Fan and 7 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. WNT4 reprograms dental pulp stem cells to resist PANoptosis and rebuild neurogenic potential for facial nerve injury repair.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  5. Review
  6. HBEGF/EGFR pathway activation by hUC-MSCs improves cognitive outcomes in anti-NMDAR encephalitis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Yali JiaStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Ning CaoStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Jinglei ZhaiStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Quan ZengStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Pei ZhengStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Ruyu SuSouth China Institute of Biomedicine Guangzhou 510005 China.
Tuling LiaoStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Jiajing LiuStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Haiyun PeiStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Zeng FanStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Junnian ZhouExperimental Hematology and Biochemistry Lab Beijing Institute of Radiation Medicine Beijing 100850 China.
Jiafei XiStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Lijuan HeStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Lin ChenStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Xue NanStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Wen YueStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.
Xuetao PeiStem Cell and Regenerative Medicine Lab Institute of Health Service and Transfusion Medicine Beijing 100850 China.ORCID https://orcid.org/0000-0002-2896-6021
Guangzhou Institutes of Biomedicine and Health · CNBeijing Radiation Center · CNPingjin Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cells have emerged as a potential therapy for a range of neural insults, but their application in Alzheimer's disease (AD) is still limited and the mechanisms underlying the cognitive benefits of stem cells remain to be elucidated. Here, the effects of clinical-grade human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) on the recovery of cognitive ability in SAMP8 mice, a senescence-accelerated mouse model of AD is explored. A functional assay identifies that the core functional factor hepatocyte growth factor (HGF) secreted from hUC-MSCs plays critical roles in hUC-MSC-modulated recovery of damaged neural cells by down-regulating hyperphosphorylated tau, reversing spine loss, and promoting synaptic plasticity in an AD cell model. Mechanistically, structural and functional recovery, as well as cognitive enhancements elicited by exposure to hUC-MSCs, are at least partially mediated by HGF in the AD hippocampus through the activation of the cMet-AKT-GSK3

Indexed as

AKT‐GSK3β signaling pathwayAlzheimer's diseasecMethepatocyte growth factorhyperphosphorylated tauumbilical cord‐derived mesenchymal stem cells

Identifiers

PMID32995116
PMCPMC7507104
OpenAlexW3040145497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.